Skip to main content

Closed

GANX: Gain Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

9thpctl

Volume

0.27×avg

Market Cap

71.66MUSD

P/E Ratio

-2.9TTM

Div Yield

-ann

Gain Therapeutics, Inc.

GANXNASDAQ Global Market·USD·Closed

Gain Therapeutics, Inc.

GANXNASDAQ·USD·Closed

$1.68

−4.55%

$1.68

−$0.08 (4.55%)

52W Range

9thpctl

Volume

0.27×avg

Mkt Cap

71.66MUSD

P/E

-2.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings